What Is the Average Price of Ozempic per Month with Medicare?

Find out typical monthly Ozempic costs for Medicare beneficiaries and coverage details.

Understanding the Average Ozempic Cost per Month for Medicare Beneficiaries

Ozempic (semaglutide) has become one of the most widely prescribed GLP‑1 receptor agonists for managing type 2 diabetes and, more recently, for weight loss. For Medicare beneficiaries, the monthly out‑of‑pocket expense can vary widely based on plan design, supplemental coverage, and pharmacy pricing. This article breaks down the typical cost range, explains how Medicare covers GLP‑1 therapies, and offers practical strategies to keep monthly expenses manageable.

How Medicare Pays for GLP‑1 Medications

Medicare Part D is the primary avenue for prescription drug coverage. Under Part D, the following components influence the amount a beneficiary pays each month:

  • Premiums – The monthly fee for the Part D plan.
  • Deductible – The amount you must pay out‑of‑pocket before insurance begins covering costs. In 2024, the standard deductible is up to $505, though many plans set lower amounts.
  • Initial and Coverage Gaps – After meeting the deductible, you enter the initial coverage phase where you typically pay 25 % of the drug’s price. If total drug spending reaches the “donut hole,” you may pay a higher share until catastrophic coverage begins.
  • Catastrophic Phase – Once you exceed the annual out‑of‑pocket threshold (approximately $7,400 in 2024), you pay a small co‑pay for each prescription.

Because Ozempic is a specialty medication, its price often exceeds the average drug cost, which can push beneficiaries into higher coverage phases more quickly.

Typical Monthly Ozempic Expense for Medicare Recipients

Based on publicly available Medicare Part D pricing data and pharmacy price surveys, the average wholesale price (AWP) for a 30‑day supply of Ozempic 0.5 mg or 1 mg is roughly $900–$1,100. After accounting for plan negotiations and discounts, the net cost to Medicare is usually lower, but the beneficiary’s share can still be significant.

Here is a general estimate of what a Medicare beneficiary might expect to pay each month, assuming standard plan structures and no additional subsidies:

  1. Without a supplemental plan (stand‑alone Part D) – Approximately $225–$275 per month after the deductible and during the initial coverage phase (25 % of the net price).
  2. With a Medicare Advantage (Part C) plan that includes drug coverage – Out‑of‑pocket costs can range from $150 to $200 per month, depending on the plan’s formulary tier and any co‑pay structures.
  3. Beneficiaries qualified for Extra Help (Low‑Income Subsidy) – Monthly costs may drop to $0–$30, as the subsidy covers most of the drug’s price.

These figures are approximate and can differ based on pharmacy location, whether a generic version becomes available, and the specific tier placement of Ozempic in a given plan’s formulary.

Comparing Ozempic with Other GLP‑1 Options

While Ozempic remains a leading GLP‑1 medication, several newer agents have entered the market, each with its own pricing dynamics:

  • Wegovy – The higher‑dose formulation of semaglutide approved for chronic weight management. Its AWP is typically 10‑15 % higher than Ozempic, leading to monthly out‑of‑pocket costs of $250–$320 for most Medicare beneficiaries.
  • Mounjaro – Tirzepatide, a dual GIP/GLP‑1 agonist, often priced similarly to Wegovy but may be placed on a higher formulary tier, increasing co‑pay amounts.
  • Zepbound – Another tirzepatide brand with comparable pricing to Mounjaro, though some plans negotiate modest discounts.

Because all of these medications fall under the GLP‑1 class, Medicare plans typically treat them similarly in terms of tier placement. However, plan‑specific negotiations can result in noticeable cost differences, so it’s worthwhile to compare options during the annual enrollment period.

Factors That Influence Your Monthly Ozempic Cost

Several variables can cause the actual amount you pay each month to differ from the average estimates above:

  • Formulary Tier – If a plan places Ozempic on a higher tier, you may pay a larger co‑pay or coinsurance.
  • Pharmacy Choice – Retail pharmacies often have higher list prices than mail‑order services, which can lower the monthly cost by up to 20 %.
  • Dosage Adjustments – Some patients start on 0.5 mg and later increase to 1 mg or 2 mg, which raises the price proportionally.
  • Supplemental Coverage – Medigap plans that include prescription drug coverage (often called “MA Medigap”) can reduce out‑of‑pocket expenses.
  • State‑Specific Programs – Certain states offer additional assistance programs for seniors, which can further lower the cost.

Strategies to Reduce Your Ozempic Out‑of‑Pocket Expense

Even with Medicare’s structured coverage, there are steps you can take to keep monthly spending under control:

  1. Shop Around – Compare prices between local pharmacies, large chains, and online/mail‑order options. The price can vary by as much as $100 per month.
  2. Use Manufacturer Coupons – Novo Nordisk occasionally offers discount cards for eligible patients, which can shave off a portion of the cost.
  3. Enroll in the Extra Help Program – If you meet income or resource thresholds, this federal subsidy can dramatically lower prescription costs.
  4. Consider a 90‑Day Supply – Some plans offer a lower per‑day cost when you fill a 90‑day prescription, reducing the number of co‑pays.
  5. Review Your Plan Annually – During the Medicare Open Enrollment Period (October 15–December 7), compare Part D plans to see if another plan offers a better tier placement or lower co‑pay for GLP‑1 drugs.

Getting Started with GLP‑1

If you are interested in beginning GLP‑1 therapy, the first step is to confirm your eligibility and understand your coverage options. Many Medicare beneficiaries find it helpful to consult a licensed online provider who can review your medical history, verify insurance details, and guide you through the prescription process. To streamline this step, you can check your eligibility here. Once eligibility is confirmed, your provider can coordinate with your pharmacy to ensure you receive the most cost‑effective option available under your plan.

Frequently Asked Questions

What is the typical out‑of‑pocket cost for Ozempic under Medicare Part D?

For most beneficiaries without additional subsidies, the monthly cost usually falls between $225 and $275 after the deductible and during the initial coverage phase. Costs can be lower with supplemental plans or the Extra Help program.

Does Medicare cover the weight‑loss dose of Ozempic (Wegovy)?

Yes, Medicare Part D can cover Wegovy if it is listed on the plan’s formulary. However, because Wegovy is a higher dose, the monthly cost is generally higher than standard Ozempic dosing, often ranging from $250 to $320.

Can I switch between Ozempic, Mounjaro, and Zepbound without changing my plan?

All three medications belong to the GLP‑1 class and are typically placed on similar formulary tiers. Switching may be possible without changing your plan, but you should verify tier placement and co‑pay amounts with your pharmacy benefits manager.

How does the Extra Help program affect my Ozempic cost?

Beneficiaries who qualify for Extra Help may pay as little as $0–$30 per month for Ozempic, as the program covers most of the drug’s price after the deductible.

Disclaimer: This article provides general information and does not constitute medical or financial advice. Always consult a qualified healthcare professional and your Medicare plan administrator for personalized guidance regarding prescription drug coverage and costs.